ACCU-CHEK Connect Personal Diabetes Management Study (PDM CONNECT)

Inclusion Criteria:

- Diagnosis of type 1 or type 2 diabetes for greater than or equal to (>=) 6 months

- Currently using insulin as a component of the diabetes therapy

- Allow and be able to provide self-monitoring of blood glucose (SMBG) data at least 1
month prior to study start

- SMBG frequency as confirmed by site SMBG data download of participants meter(s): Basal
insulin treated participants - SMBG >=5 times per week and Multiple dose insulin
participants - SMBG >=2 times per day

- Glycosylated hemoglobin (HbA1c) of >=7.5 percentage (per local laboratory obtained
less than or equal to [<= 3] months of Baseline)

- Able to read and write in English language

- Currently using a Smartphone and have experience with downloading at minimum one
application

- Smartphone compatibility; must be able to download the ACCU-CHEK Connect system
application accordingly

- Naive to the ACCU-CHEK Connect system

- Willing to comply with study procedures

Exclusion Criteria:

- Treatment with insulin pump therapy

- Any use of continuous glucose monitoring (CGM) to manage their diabetes during the
course of the study

- Visually impaired

- Women who are pregnant, lactating or planning to become pregnant during the study
period

- Diagnosed with any clinically significant condition (for example anemia, major organ
system disease, infections, psychosis or cognitive impairment)

- Participant requires chronic steroid in adrenal suppressive doses, other
immuno-modulatory medication or chemotherapy

- Participant is the investigator or any sub-investigator, general practitioner,
practice staff, pharmacist, research assistant or other staff or relative of those
directly involved in the conduct of the study and design of the protocol